Canada Gastrointestinal Endoscopic Devices Market Insight
The Canada gastrointestinal endoscopic devices market size is growing at a 6.46% CAGR, driven by the increasingly integrating AI-assisted imaging systems, smart visualization technologies, and minimally invasive therapeutic endoscopy solutions.
Canada Gastrointestinal Endoscopic Devices Market Insights Forecasts to 2035
- The Canada Gastrointestinal Endoscopic Devices Market Size Was Estimated at USD270.1 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.46% from 2025 to 2035
- The Canada Gastrointestinal Endoscopic Devices Market Size is Expected to Reach USD 505.2 Million by 2035
Notable Insights for Canada Gastrointestinal Endoscopic Devices Market
- By product type, colonoscopes dominated almost 35-36% of the Canada gastrointestinal endoscopic devices market in 2025 due to the growing trend of colorectal cancer screening programs, increasing preventive diagnostics, and the use of advanced technologies in diagnosing diseases in the country.
- By application, diagnostic endoscopy constituted around 40-41% of the market share for Canada gastrointestinal endoscopic devices market in 2025 owing to the increasing need for early diagnosis of diseases, the trend of minimal invasive surgeries, and the use of advanced imaging technologies across the healthcare industry.
Download the eBook (ToC)
- Health Canada regulates the Canada gastrointestinal endoscopic devices market through stringent medical device regulations, adherence to high safety standards, approval of advanced imaging technologies, and quality compliance of endoscopic devices throughout Canada.
- The Canadian Partnership Against Cancer supports the growth of the Canada gastrointestinal endoscopic devices market through the promotion of colorectal cancer screening programs, early detection programs, and awareness programs.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Canada gastrointestinal endoscopic devices market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Canada Gastrointestinal Endoscopic Devices Market
- Olympus Corporation
- Fujifilm Holdings Corporation
- HOYA Corporation (PENTAX Medical)
- Medtronic plc
- Boston Scientific Corporation
- Karl Storz SE & Co. KG
- Stryker Corporation
- Conmed Corporation
- Cook Medical
- Johnson & Johnson MedTech
Recent Developments:
- In February 2025, the Canada gastrointestinal endoscopic devices market advanced as AI-assisted colonoscopy systems gained traction, improving polyp detection and screening efficiency, supported by rising healthcare investments and enhanced clinical trial-driven adoption across Canada.
Market Segmentation:
Canada Gastrointestinal Endoscopic Devices Market, By Product Type
- Gastroscopes
- Colonoscopes
- Enteroscopes
- Duodenoscopes
- Capsule Endoscopy Systems
- Others
Canada Gastrointestinal Endoscopic Devices Market, By Application
- Diagnostic Endoscopy
- Therapeutic Endoscopy
- Cancer Screening
- Polyp Removal
- Others
Canada Gastrointestinal Endoscopic Devices Market, By End User
- Hospitals
- Specialty Gastroenterology Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
Canada Gastrointestinal Endoscopic Devices Market, By Technology
- HD Endoscopy
- AI-Assisted Endoscopy
- Narrow Band Imaging
- Others
Expert Views:
The Canada gastrointestinal endoscopic devices market will see considerable growth during its long term due to factors such as increased awareness of preventive healthcare, increasing prevalence of minimally invasive techniques and artificial intelligence in the diagnostic process. Early diagnosis of cancer and other diseases, along with outpatient treatment, are considered the main drivers for growth.